First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
Toronto, Ontario, July 07, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (“PurMinds” or the “Company”), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative...
Toronto, Ontario, July 06, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (“PurMinds” or the “Company”), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative...
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 127 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA.